Published in Neurourol Urodyn on January 01, 2007
National trends in the usage and success of sacral nerve test stimulation. J Urol (2011) 1.27
Suppression of bladder overactivity by activation of somatic afferent nerves in the foot. BJU Int (2011) 1.21
Post-stimulation inhibitory effect on reflex bladder activity induced by activation of somatic afferent nerves in the foot. J Urol (2011) 1.06
Influence of naloxone on inhibitory pudendal-to-bladder reflex in cats. Exp Neurol (2010) 1.00
Involvement of opioid receptors in inhibition of bladder overactivity induced by foot stimulation in cats. J Urol (2012) 0.93
A modified approach to patient's selection with improved clinical outcomes in sacral nerve modulation. Can Urol Assoc J (2011) 0.91
Pelvic electrical neuromodulation for the treatment of overactive bladder symptoms. Adv Urol (2011) 0.87
Sacral nerve stimulation: neuromodulation for voiding dysfunction and pain. Neurotherapeutics (2008) 0.87
Neuromodulation for overactive bladder. Nat Rev Urol (2013) 0.87
Combination of foot stimulation and tramadol treatment reverses irritation induced bladder overactivity in cats. J Urol (2012) 0.85
Sacral neuromodulation and refractory overactive bladder: an emerging tool for an old problem. Ther Adv Urol (2012) 0.83
Refractory overactive bladder: Beyond oral anticholinergic therapy. Indian J Urol (2007) 0.82
Sacral neuromodulation for lower urinary tract dysfunction. World J Urol (2011) 0.81
Battery explantation after sacral neuromodulation in the Medicare population. Neurourol Urodyn (2012) 0.80
Sacral neuromodulation: Therapy evolution. Indian J Urol (2010) 0.79
Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series. BMC Urol (2015) 0.79
A systematic review of clinical studies of electrical stimulation for treatment of lower urinary tract dysfunction. Int Urogynecol J (2012) 0.78
Contrasting the percutaneous nerve evaluation versus staged implantation in sacral neuromodulation. Curr Urol Rep (2010) 0.77
Initial experience with sacral neuromodulation for the treatment of lower urinary tract dysfunction in Brazil. Int Braz J Urol (2016) 0.75
Surgical options for drug-refractory overactive bladder patients. Rev Urol (2010) 0.75
Improvement of bowel dysfunction with sacral neuromodulation for refractory urge urinary incontinence. Int Urogynecol J (2011) 0.75
Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol (2009) 2.06
Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol (2010) 1.42
Ureteroscopic laser lithotripsy for upper urinary tract calculi with active fragment extraction and computerized tomography followup. J Urol (2006) 0.95
Endoscopic removal of intravesical polypropylene sling with the holmium laser. J Urol (2004) 0.95
Confident intraoperative decision making during percutaneous nephrolithotomy: does this patient need a second look? Urology (2008) 0.95
Irrigation and drainage properties of three-way urethral catheters. Urology (2006) 0.92
Evaluation of efficacy of four laparoscopic needle drivers. JSLS (2008) 0.86
Procedural techniques in sacral nerve modulation. Int Urogynecol J (2010) 0.86
Treatment of stress incontinence with the SPARC sling: intraoperative and early complications of 445 patients. Urology (2005) 0.85
Intraoperative fragment detection during percutaneous nephrolithotomy: evaluation of high magnification rotational fluoroscopy combined with aggressive nephroscopy. J Urol (2006) 0.85
Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence. BJU Int (2007) 0.82
Physicians, guidelines, and cognitive tasks. Eval Health Prof (2010) 0.82
Exogenous endoscopy-related infections, pseudo-infections, and toxic reactions: clinical and economic burden. Curr Med Res Opin (2006) 0.82
Patient identified needs for chronic obstructive pulmonary disease versus billed services for care received. Int J Chron Obstruct Pulmon Dis (2008) 0.79
Sacral neuromodulation: Therapy evolution. Indian J Urol (2010) 0.79
Building a partnership with health plans: the Minneapolis and St. Paul Controlling Asthma in American Cities Experience. J Urban Health (2011) 0.78
The fractured flexible ureteroscope with locked deflection. J Urol (2004) 0.76
Sacral nerve modulation in overactive bladder. Curr Urol Rep (2010) 0.76
Real-World Retention Rates After Intravesical OnabotulinumtoxinA for Idiopathic Overactive Bladder. Female Pelvic Med Reconstr Surg (2017) 0.75
Machine Versus Man: Can Robotic Mops Clean to Lead Safety Standards? J Environ Health (2017) 0.75